Generated by AI
Telix Pharmaceuticals Limited American Depositary Shares is a depositary share security representing ordinary shares of Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company focused on therapeutic and diagnostic radiopharmaceuticals. The company develops and commercializes products across oncology and precision medicine, with an emphasis on targeted radioactive medicines used in cancer care and medical imaging. Its current business spans therapeutics, precision medicine, and manufacturing solutions, supporting the discovery, production, and delivery of radiopharmaceutical products and related technologies. Telix Pharmaceuticals Limited also works with healthcare providers, hospitals, and research partners in markets that rely on specialized nuclear medicine and molecular imaging tools. As an American Depositary Share, it provides U.S. investors with a U.S.-traded form of exposure to the company’s ordinary shares while the underlying business remains centered on its biopharmaceutical operations.
The latest articles about TLX.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Telix Pharmaceuticals maintains a Buy rating, driven by robust 3Q26 performance and the strategic ITM acquisition. Read more on TLX stock here.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Summary of Sep 14's posts. Generated by AI.
No summary yet.
Summary of Feb 20's posts. Generated by AI.
Summary of Aug 28's posts. Generated by AI.
Investors talking about TLX also mention these. Each card shows that asset’s own numbers for the past 24 hours.